Assyro AI
Orange Book product · Generic (ANDA)

Benazepril Hydrochloride

Benazepril Hydrochloride

Generic (ANDA)ANDA 078212TE AB Aurobindo Pharma
Approved
May 22, 2008
Application
Generic (ANDA)
TE code
AB
Listed patents
0
Benazepril Hydrochloride (Benazepril Hydrochloride) is a generic drug approved under an ANDA (078212) in 2008, marketed by Aurobindo Pharma. Its therapeutic-equivalence code is AB, so the FDA considers it substitutable for the reference brand.

Sourced from the FDA Orange Book

Approval, patents, exclusivity

Key dates

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 22, 2008

    18 yr 5 mo ago

  2. Today

FDA product record

Pharmaceutical detail

Pharmaceutical detail

Active ingredient

BENAZEPRIL HYDROCHLORIDE

Strength

40MG

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

ANDA 078212

Product number

003

Marketing status

Prescription

Reference listed drug (RLD)

No

Reference standard (RS)

Yes

Same application

Other strengths in ANDA 078212

Brand + generics

Active-ingredient family

Orange Book patent file

Listed patents

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Benazepril Hydrochloride — frequently asked questions

Approval, therapeutic equivalence, patents, and exclusivity for this product, from the FDA Orange Book.

Built directly from the FDA Orange Book data file. This product page links back to the Benazepril Hydrochloride active-ingredient family, which is the canonical reference for generics, patents, and exclusivity across all strengths.

Related FDA reference tools

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.